Dysferlin gene therapy(Genotarget) | Interleukin Related interleukin-related.com

Product Name :
Dysferlin gene therapy(Genotarget)

Search keywords :
Dysferlin

drugId :
null

Target Vo:
Not applicable

Target Vo Short Name :
Not applicable

Moa_Name:
Gene transference

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :

Active Company_Name :

Active Indication_Name:
Muscular Dystrophies, Limb-Girdle

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Alkaline Phosphatase Antibody
Casein Kinase 1 alpha Antibody
Cy3-conjugated AffiniPure Goat Anti-Mouse IgG H&L: Cy3-conjugated AffiniPure Goat Anti-Mouse IgG H&Lis an -conjugated, goat-derived anti-mouse IgG antibody. Cy3-conjugated AffiniPure Goat Anti-Mouse IgG H&L conjugates the light and heavy chains of mouse IgG antibodies for use in ICC/IF, IHC-F, FC, ELISA experiments in the mouse context.

Author: Interleukin Related

Related Posts